NUCLEIX
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
NUCLEIX
Industry:
Biotechnology Health Care Information Technology Manufacturing Medical Device Personal Health
Founded:
2008-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.nucleix.com
Total Employee:
11+
Status:
Active
Contact:
+97289161616
Email Addresses:
[email protected]
Total Funding:
82.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Angeion Corporation
Angeion Corp develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems.
CROSSWAY
CROSSWAY develops and manufactures physical fitness diagnostic systems and measuring devices.
eWAVE
eWAVE develops, manufactures, and markets optical transport systems.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Current Advisors List
Current Employees Featured
Founder
Investors List
Zohar Zisapel
Zohar Zisapel investment in Venture Round - Nucleix
RA Capital Management
RA Capital Management investment in Venture Round - Nucleix
Sands Capital Ventures
Sands Capital Ventures investment in Venture Round - Nucleix
OrbiMed
OrbiMed investment in Venture Round - Nucleix
OCI Bio Investments
OCI Bio Investments investment in Venture Round - Nucleix
BlackRock
BlackRock investment in Venture Round - Nucleix
DSC Investment
DSC Investment investment in Venture Round - Nucleix
RA Capital Management
RA Capital Management investment in Venture Round - Nucleix
OrbiMed
OrbiMed investment in Venture Round - Nucleix
MILFAM
MILFAM investment in Venture Round - Nucleix
Official Site Inspections
http://www.nucleix.com Semrush global rank: 9.84 M Semrush visits lastest month: 95
- Host name: 172.66.43.63
- IP address: 172.66.43.63
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nucleix"
Nucleix – Company
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based …See details»
Nucleix – About Us
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach …See details»
Nucleix
Nucleix R&D has the capabilities and experience to develop additional liquid biopsy assays for other types of cancerSee details»
Nucleix - Crunchbase Company Profile & Funding
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation …See details»
Nucleix Company Profile 2024: Valuation, Funding & Investors
Developer of non-invasive molecular diagnostic tests designed to facilitate and ensure accurate and effective cancer detection. The company leverages DNA methylation patterns to detect …See details»
Nucleix - Org Chart, Teams, Culture & Jobs - The Org
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products …See details»
Nucleix Ltd. - VentureRadar
"Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging …See details»
Nucleix Receives CAP Accreditation and CLIA ... - Business Wire
Oct 19, 2022 · SAN DIEGO & REHOVOT, Israel-- (BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced …See details»
Nucleix Company Profile - Office Locations, Competitors ... - Craft
Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. They are based on the identification of subtle changes in methylation …See details»
Nucleix Announces Recent Advancements in Early Lung …
Jan 5, 2022 · SAN DIEGO & REHOVOT, Israel-- ( BUSINESS WIRE )--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced recent advances in its EpiCheck ®...See details»
Nucleix Raises $77 Million for New Lung Cancer Detection Tech
Jan 6, 2022 · Nucleix, an Israeli medtech startup that offers a liquid biopsy which it says can detect cancer early, secured an additional $22 million in funding, as an extension to the …See details»
Nucleix Secures $55 Million Funding Led by RA Capital …
Apr 7, 2021 · SAN DIEGO & REHOVOT, Israel-- ( BUSINESS WIRE )-- Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 …See details»
Nucleix - Overview, News & Similar companies | ZoomInfo.com
Apr 4, 2024 · View Nucleix (www.nucleix.com) location in Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Nucleix Raises Additional $22M - Precision Medicine Online
Jan 5, 2022 · Nucleix is developing liquid biopsy tests for early-stage and recurring cancer diagnosis that use PCR and next-generation sequencing technologies to detect tissue-specific …See details»
Liquid biopsy maker Nucleix rakes in $55M to develop blood tests …
Apr 8, 2021 · It’s full steam ahead for Nucleix’s blood test for lung cancer detection, thanks to an influx of cash in the Israeli company’s latest round of funding. The liquid biopsy maker closed its...See details»
☑️Nucleix — Consulting Organization,Supplier from Israel, …
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic bio markers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products …See details»
Nucleix – United States
Bladder EpiCheck ®, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary cancer, and FDA 510 (k) cleared for bladder cancer recurrence …See details»
Nucleix – Technology
Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our platform delivers highly …See details»
Nucleix – News&Events
Jun 11, 2023 · A. Menarini Diagnostics and Nucleix Announce a Strategic Partnership for a Non-Invasive Bladder Cancer Test in EuropeSee details»